Doris R. Siwak

2.5k citations

27 papers · 1.7k indexed · h-index 18

Molecular Biology top 10%
Oncology top 5%
Cancer Research top 10%
Pulmonary and Respiratory Medicine top 10%
Cell Biology top 10%

Co-authors: Gordon B. Mills Bharat B. Aggarwal Shishir Shishodia Razelle Kurzrock Yiling Lu T. Christopher Windham Gary E. Gallick Justin M. Summy
Topics: Monoclonal and Polyclonal Antibodies Research (5 papers)Advanced Biosensing Techniques and Applications (4 papers)Advanced Proteomics Techniques and Applications (3 papers)
Cited by: Molecular Medicine Oncology Molecular Biology
Journals: Nature Communications Nature Genetics Bioinformatics
Partner nations: United States Japan Canada

In The Last Decade

Doris R. Siwak

27 papers receiving 1.6k citations

Peers

Countries citing papers authored by Doris R. Siwak

Since Specialization

Citations

This map shows the geographic impact of Doris R. Siwak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris R. Siwak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris R. Siwak more than expected).

Fields of papers citing papers by Doris R. Siwak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris R. Siwak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris R. Siwak. The network helps show where Doris R. Siwak may publish in the future.

Co-authorship network of co-authors of Doris R. Siwak

This figure shows the co-authorship network connecting the top 25 collaborators of Doris R. Siwak. A scholar is included among the top collaborators of Doris R. Siwak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris R. Siwak. Doris R. Siwak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proteo-genomic characterization of virus-associated liver cancers reveals potential subtypes and therapeutic targets 2022 ·Nature Communications ·Masashi Fujita,Mei-Ju May Chen,Doris R. Siwak,Shota Sasagawa,(unknown),Koji Arihiro,Atsushi Ono,Ryoichi Miura,Kazuhiro Maejima,Hiroshi Aikata,Masaki Ueno,Shinya Hayami,Hiroki Yamaue,Kazuaki Chayama,Ju‐Seog Lee,Yiling Lu,Gordon B. Mills,Han Liang,Satoshi Nishizuka,Hidewaki Nakagawa	13
2	Frequent post-operative monitoring of colorectal cancer using individualised ctDNA validated by multiregional molecular profiling 2021 ·British Journal of Cancer ·(unknown),Takeshi Iwaya,Noriyuki Sasaki,Masashi Fujita,Zhenlin Ju,Doris R. Siwak,Tsuyoshi Hachiya,Kei Sato,Fumitaka Endo,Toshimoto Kimura,Koki Otsuka,Ryo Sugimoto,Tamotsu Sugai,Lance A. Liotta,Yiling Lu,Gordon B. Mills,Hidewaki Nakagawa,Satoshi Nishizuka	7
3	Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA 2020 ·PLoS ONE ·Noriyuki Sasaki,Takeshi Iwaya,(unknown),Masashi Fujita,Zhenlin Ju,Fumitaka Endo,(unknown),Tsuyoshi Hachiya,Ryo Sugimoto,Tamotsu Sugai,Doris R. Siwak,Lance A. Liotta,Yiling Lu,Gordon B. Mills,Hidewaki Nakagawa,Satoshi Nishizuka	4
4	Analytical Platforms 3: Processing Samples via the RPPA Pipeline to Generate Large-Scale Data for Clinical Studies 2019 ·Advances in experimental medicine and biology ·Doris R. Siwak,Jun Li,Rehan Akbani,Han Liang,Yiling Lu	12
5	GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity 2019 ·Oncogene ·(unknown),Matthew G. Annis,Patricia MacDonald,Caterina Russo,(unknown),Doris R. Siwak,Gordon B. Mills,Peter M. Siegel	36
6	Suppression of Nuclear Factor-κB by Glucocorticoid Receptor Blocks Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer Cells 2019 ·Molecular Cancer Therapeutics ·Ping Fan,Doris R. Siwak,(unknown),Fadeke A. Agboke,Smitha Yerrum,V. Craig Jordan	20
7	LKB1 is a central regulator of tumor initiation and pro-growth metabolism in ErbB2-mediated breast cancer 2013 ·Cancer & Metabolism ·Fanny Dupuy,Takla Griss,Julianna Blagih,Gaëlle Bridon,Daina Avizonis,Ling Chen,Zhifeng Dong,Doris R. Siwak,Matthew G. Annis,Gordon B. Mills,William J. Muller,Peter M. Siegel,Russell G. Jones	39
8	Small Molecule ErbB Inhibitors Decrease Proliferative Signaling and Promote Apoptosis in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia 2013 ·PLoS ONE ·Mary E. Irwin,Laura D. Nelson,(unknown),(unknown),Claudia P. Miller,Shana L. Palla,Doris R. Siwak,Gordon B. Mills,Zeev Estrov,Shulin Li,Steven M. Kornblau,Dennis P.M. Hughes,Joya Chandra	18
9	Tumor Epidermal Growth Factor Receptor and EGFR PY1068 Are Independent Prognostic Indicators for Head and Neck Squamous Cell Carcinoma 2012 ·Clinical Cancer Research ·Sarah Wheeler,Doris R. Siwak,Raymond L. Chai,Courtney R. LaValle,Raja R. Seethala,Lin Wang,Kathleen Cieply,(unknown),Corwin Joy,Gordon B. Mills,Athanassios Argiris,Jill M. Siegfried,Jennifer R. Grandis,Ann Marie Egloff	63
10	Cetuximab Attenuates Metastasis and u-PAR Expression in Non–Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity 2009 ·Cancer Research ·Dessislava A. Nikolova,Irfan A. Asangani,Laura D. Nelson,Dennis P.M. Hughes,Doris R. Siwak,Gordon B. Mills,(unknown),(unknown),Lothar R. Pilz,Christian Manegold,Heike Allgayer	23
11	Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: Accurate detection of CA19‐9 levels in pancreatic cancer 2008 ·PROTEOMICS ·Tobias Grote,Doris R. Siwak,Herbert A. Fritsche,Corwin Joy,Gordon B. Mills,Diane M. Simeone,David C. Whitcomb,Craig D. Logsdon	66
12	A module of negative feedback regulators defines growth factor signaling 2007 ·Nature Genetics ·Ido Amit,Ami Citri,Tal Shay,Yiling Lu,Menachem Katz,Fan Zhang,Gabi Tarcic,Doris R. Siwak,John Lahad,Jasmine Jacob‐Hirsch,Ninette Amariglio,Nora Vaisman,Eran Segal,Gideon Rechavi,Uri Alon,Gordon B. Mills,Eytan Domany,Yosef Yarden	360
13	Telomere 3′ overhang‐specific DNA oligonucleotides induce autophagy in malignant glioma cells 2007 ·The FASEB Journal ·Hiroshi Aoki,Eiji Iwado,Mark S. Eller,Yasuko Kondo,Keishi Fujiwara,(unknown),Kenneth R. Hess,Doris R. Siwak,Raymond Sawaya,Gordon B. Mills,Barbara A. Gilchrest,Seiji Kondo	58
14	Identification of selective inhibition of phospho-S6 ribosomal protein in XK469 sensitive leukemia cell lines using functional proteomic analysis 2005 ·Cancer Research ·Raoul Tibes,Yiling Lu,Doris R. Siwak,Bryan T. Hennessy,Ruth LaPushin,Gordon B. Mills	2
15	Curcumin‐induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IκB kinase and nuclear factor κB activity and are independent of the B‐Raf/mitogen‐activated/extracellular signal‐regulated protein kinase pathway and the Akt pathway 2005 ·Cancer ·Doris R. Siwak,Shishir Shishodia,Bharat B. Aggarwal,Razelle Kurzrock	192
16	The HER2/Grb2/Akt pathway regulates the DNA binding activity of AP-1 in breast cancer cells 2004 ·Oncology Reports ·Edgar Mendoza-Gamboa,Doris R. Siwak,Ana M. Tari	7
17	KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2 2004 ·Clinical & Experimental Metastasis ·Xiaoping Zang,Doris R. Siwak,(unknown),Ana M. Tari,J. Thomas Pento	21
18	Liposomal Antisense Oligonucleotides for Cancer Therapy 2004 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Doris R. Siwak,Ana M. Tari,Gabriel Lopez‐Berestein	5
19	The potential of drug-carrying immunoliposomes as anticancer agents. Commentary re: J. W. Park et al., Anti-HER2 immunoliposomes: enhanced efficacy due to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002. 2002 ·PubMed ·Doris R. Siwak,Ana M. Tari,Gabriel Lopez‐Berestein	37
20	Src activation regulates anoikis in human colon tumor cell lines 2002 ·Oncogene ·T. Christopher Windham,Nila U. Parikh,Doris R. Siwak,Justin M. Summy,David J. McConkey,Alan J. Kraker,Gary E. Gallick	173

About Doris R. Siwak

Doris R. Siwak is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 27 papers that have together received 1.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Advanced Biosensing Techniques and Applications (4 papers) and Advanced Proteomics Techniques and Applications (3 papers). The work is most often cited by research in Molecular Medicine (114 citations), Oncology (462 citations) and Molecular Biology (1.2k citations). Doris R. Siwak has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Gordon B. Mills, Bharat B. Aggarwal, Shishir Shishodia, Razelle Kurzrock, Yiling Lu, T. Christopher Windham, Gary E. Gallick, Justin M. Summy, Alan J. Kraker and David J. McConkey. Their work appears in journals such as Nature Communications, Nature Genetics and Bioinformatics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact